Legend Biotech Corporation
Open: 1:24 PM
LEGN Stock Price Graph
LEGN Stock Price Today
Legend Biotech Corporation (LEGN) stock declined over -3.20% intraday to trade at $59.28 a share on NASDAQ. The stock opened with a gain of 4.48% at $64.17 and touched an intraday high of $65.21, falling -3.48% against the last close of $61.42. The Legend Biotech Corporation in stock market went to a low of $63.52 during the session.
LEGN Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
LEGN Stock Price History Chart
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comparison of the treatment with standard triplet therapy in revlimid-refractory multiple myeloma. The company also has a portfolio of earlier-stage autologous product candidates, which are in Phase I clinical trials for the treatment of gastric cancer and T cell lymphoma. In addition, it is developing CAR-T product candidates targeting CD20/CD22/CD19 for the treatment of non-hodgkins lymphoma, diffuse large B-cell lymphoma, and acute lymphoblastic leukemia. Further, the company has product candidates in early preclinical and clinical development for the treatment of solid tumors as well as infectious diseases. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. Legend Biotech Corporation was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation.
Frequently Asked Questions
What is the current Legend Biotech Corporation (LEGN) stock price?
Legend Biotech Corporation (NASDAQ: LEGN) stock price is $59.28 in the last trading session. During the trading session, LEGN stock reached the peak price of $65.21 while $63.52 was the lowest point it dropped to. The percentage change in LEGN stock occurred in the recent session was -3.20% while the dollar amount for the price change in LEGN stock was -$1.96.
LEGN's industry and sector of operation?
The NASDAQ listed LEGN is part of Biotechnology industry that operates in the broader Healthcare sector. Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comparison of the treatment with standard triplet therapy in revlimid-refractory multiple myeloma.
Who are the executives of LEGN?
Ms. Liz Gosen
Senior Vice President of Global Technical Operations
Executive Director of Strategic Marketing & Corporation Communications
Dr. Ying Huang Ph.D.
Chief Executive Officer & Director
Dr. Guowei Fang Ph.D.
Senior Vice President & Global Head of Research and Early Devel.
How LEGN did perform over past 52-week?
LEGN's closing price is 1.04% higher than its 52-week low of $42.905 where as its distance from 52-week high of $77.32 is -0.04%.
How many employees does LEGN have?
Number of LEGN employees currently stands at N/A. LEGN operates from 2101 Cottontail Lane, Somerset, NJ 08873, US.
Link for LEGN official website?
Official Website of LEGN is: https://www.legendbiotech.com
How do I contact LEGN?
How many shares of LEGN are traded daily?
LEGN stock volume for the day was 973479.00 shares. The average number of LEGN shares traded daily for last 3 months was 719.49 Thousands.
What is the market cap of LEGN currently?
The market value of LEGN currently stands at $10.78 Billion with its latest stock price at $59.28 and N/A of its shares outstanding.